Loading stock research

Veridien Climate Action ETF

CLIA

Financial ServicesAMEXUS

Sign in to save

$18.61

-$0.035 (-0.19%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

CLIA News

News and disclosures filtered by period, publisher, and event group.

4 / 4

Filter options

Results

Select a headline to open the full news page in the app.

May 31, 2026, 9:00 AMgurufocus.comCLIA

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual

Financial reports

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the GalleriÂ Test Substantially Increased Cancer Detection With R

May 30, 2026, 9:00 AMgurufocus.comCLIA

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting

Financial reportsBoard decisions and meetings

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting

May 29, 2026, 6:00 AMgurufocus.comCLIA

Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma

Company announcements

[url="]Natera, Inc.[/url] (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced a new collaboration with Diakonos Oncology C

Mar 30, 2026, 11:22 PMseekingalpha.comCLIA

Lumos Diagnostics Holdings Limited (LDXHF) Discusses CLIA Waiver Clearance for FebriDx, Capital Raise, and Commercialization Strategy Transcript

Prospectus, capital raise, listing

Lumos Diagnostics Holdings Limited (LDXHF) Discusses CLIA Waiver Clearance for FebriDx, Capital Raise, and Commercialization Strategy Transcript

Loading disclosure news